Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155

1.

Capacity building for universal eye health coverage in South East Asia beyond 2020.

Das T, Keeffe J, Sivaprasad S, Rao GN.

Eye (Lond). 2020 Feb 10. doi: 10.1038/s41433-020-0801-8. [Epub ahead of print]

PMID:
32042185
2.

Aspergillus Endophthalmitis: Clinical Presentations and Factors Determining Outcomes.

Dave VP, Pappuru RR, Pathengay A, Gupta R, Joseph J, Sharma S, Das T.

Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb;9(1):9-13. doi: 10.1097/01.APO.0000617928.43993.7e.

PMID:
31990739
3.

Endophthalmitis Management: Stain-Culture, Empirical Treatment, and Beyond.

Das T.

Asia Pac J Ophthalmol (Phila). 2020 Jan-Feb;9(1):1-3. doi: 10.1097/01.APO.0000617904.11979.ae. No abstract available.

PMID:
31990737
4.

CLINICAL PRESENTATIONS, DIAGNOSIS, AND MANAGEMENT OUTCOMES OF CURVULARIA ENDOPHTHALMITIS AND A REVIEW OF LITERATURE.

Dave VP, Joseph J, Pathengay A, Pappuru RR, Das T.

Retina. 2020 Feb;40(2):370-375. doi: 10.1097/IAE.0000000000002375.

PMID:
31972808
5.
6.

Two hundred glorious years of Egmore Eye Hospital, Chennai.

Natarajan S, Nair AG, Babu MA, Das T.

Indian J Ophthalmol. 2020 Feb;68(2):309-310. doi: 10.4103/ijo.IJO_718_19. No abstract available.

7.

Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 4. Glaucoma in people with type 2 diabetes mellitus.

Behera UC, Bhattacharjee H, Das T, Gilbert C, Murthy GVS, Rajalakshmi R, Pant HB; SPEED study group.

Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S32-S36. doi: 10.4103/ijo.IJO_1948_19.

8.

Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus.

Bhattacharjee H, Barman M, Misra D, Multani PK, Dhar S, Behera UC, Das T, Gilbert C, Murthy GVS, Rajalakshmi R, Pant HB; SPEED study group.

Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S27-S31. doi: 10.4103/ijo.IJO_1934_19.

9.

Spectrum of eye disorders in diabetes (SPEED) in India. Report # 2. Diabetic retinopathy and risk factors for sight threatening diabetic retinopathy in people with type 2 diabetes in India.

Rajalakshmi R, Behera UC, Bhattacharjee H, Das T, Gilbert C, Murthy GVS, Pant HB, Shukla R; SPEED Study group.

Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S21-S26. doi: 10.4103/ijo.IJO_21_19.

10.

Spectrum of eye disorders in diabetes (SPEED) in India: Eye care facility based study. Report # 1. Eye disorders in people with type 2 diabetes mellitus.

Das T, Behera UC, Bhattacharjee H, Gilbert C, Murthy GVS, Rajalakshmi R, Pant HB, Shukla R; SPEED Study group.

Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S16-S20. doi: 10.4103/ijo.IJO_33_19.

11.

Reaching the last mile in eye care.

Das T.

Indian J Ophthalmol. 2020 Feb;68(Suppl 1):S3-S5. doi: 10.4103/ijo.IJO_2367_19. No abstract available.

12.

Aspergillus Endophthalmitis: Clinical Presentations and Factors Determining Outcomes.

Dave VP, Pappuru RR, Pathengay A, Gupta R, Joseph J, Sharma S, Das T.

Asia Pac J Ophthalmol (Phila). 2020 Jan 13. doi: 10.1097/01.APO.0000617928.43993.7e. [Epub ahead of print]

PMID:
31934884
13.

Endophthalmitis Management: Stain-Culture, Empirical Treatment, and Beyond.

Das T.

Asia Pac J Ophthalmol (Phila). 2020 Jan 13. doi: 10.1097/01.APO.0000617904.11979.ae. [Epub ahead of print] No abstract available.

PMID:
31934883
14.

Characteristics of 'sawtooth shunt' following anti-vascular endothelial growth factor for aggressive posterior retinopathy of prematurity.

Padhi TR, Das T, Kaur P, Sutar S, Khalsa A, Modi R, Ali H, Pradhan L, Jalali S.

Int Ophthalmol. 2020 Jan 10. doi: 10.1007/s10792-019-01269-4. [Epub ahead of print]

PMID:
31925658
15.

Enterobacter endophthalmitis: Clinical settings, susceptibility profile, and management outcomes across two decades.

Dave VP, Pathengay A, Behera S, Joseph J, Sharma S, Pappuru RR, Das T.

Indian J Ophthalmol. 2020 Jan;68(1):112-117. doi: 10.4103/ijo.IJO_693_19.

16.

Evidence-based practice versus economics in treatment of macular edema secondary to central retinal vein occlusion in India.

Rani PK, Das T.

Eye (Lond). 2020 Feb;34(2):217-218. doi: 10.1038/s41433-019-0709-3. Epub 2019 Nov 25. No abstract available.

PMID:
31767969
17.
18.

Does ophthalmic-grade silicone oil possess antimicrobial properties?

Dave VP, Joseph J, Jayabhasker P, Pappuru RR, Pathengay A, Das T.

J Ophthalmic Inflamm Infect. 2019 Nov 1;9(1):20. doi: 10.1186/s12348-019-0187-6.

19.

Bilateral Purtscher-like retinopathy with macular ischemia in preeclampsia secondary to antiphospholipid syndrome.

Raval V, Das T.

Indian J Ophthalmol. 2019 Nov;67(11):1883. doi: 10.4103/ijo.IJO_792_19. No abstract available.

20.

Ophthalmology residency training in India: Comparing feedback about how the training equips ophthalmologists to combat retinal diseases. READS report #6.

Gogate P, Biswas P, Das T, Nirmalan P, Natarajan S.

Indian J Ophthalmol. 2019 Nov;67(11):1816-1819. doi: 10.4103/ijo.IJO_1960_18.

Supplemental Content

Loading ...
Support Center